ACRV Dividend History & Analysis | N/A Yield
ACRV has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| JBIO | 280 M | 24.5% | 0.31% |
| ABBV | 403,217 M | 2.88% | 9.37% |
| GILD | 150,063 M | 2.66% | 6.57% |
| AMGN | 159,344 M | 3.21% | 5.07% |
| HLN | 41,758 M | 1.93% | 2.46% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| GRFS | 8,004 M | 127% | 60.7% |
| HLN | 41,758 M | 51.0% | 100% |
| AMGN | 159,344 M | 8.90% | 100% |
| ABBV | 403,217 M | 7.06% | 100% |
| GILD | 150,063 M | 3.16% | 100% |
Similar Stocks with Attractive Dividends - Compare ACRV Dividends with its Peer-Group
2.88% Yield
3.21% Yield
2.66% Yield
1.93% Yield
ACRV Dividend History: as of October 2025
No dividends paid yet.ACRV Dividend FAQ
Acrivon Therapeutics, Inc. (NASDAQ: ACRV) is a clinical-stage biotech focused on oncology drugs that are paired with proprietary companion diagnostics generated through its AP3 (Acrivon Predictive Precision Proteomics) platform. Its lead asset, ACR-368, is a selective CHK1/CHK2 inhibitor being evaluated in endometrial, platinum-resistant ovarian cancers and squamous cell carcinomas such as SCCHN and anal cancer. The pipeline also includes ACR-2316, a dual WEE1/PKMYT1 inhibitor, and a preclinical cell-cycle program derived from AP3 and co-crystallography data.
What is the Dividend Yield of ACRV?
As of October 2025, ACRV`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 1.98.Does ACRV pay a dividend?
As of October 2025 ACRV does not pay a dividend.How often does ACRV pay dividends?
Over the last 12 months, ACRV has issued dividend payments.Will ACRV pay dividends in 2025?
The next Ex-Dividend date for Acrivon Therapeutics (ACRV) is currently unknown.What is the next Ex-Dividend Date for ACRV?
The next Ex-Dividend date for Acrivon Therapeutics (ACRV) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of ACRV?
ACRV's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of ACRV?
ACRV's 5-Year Yield on Cost is -%. If you bought ACRV's shares at 16.64 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of ACRV?
ACRV Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does ACRV have a good Dividend Yield?
ACRV`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of ACRV?
The Dividend Payout Ratio of ACRV is unknown.What is the Dividend Rating of ACRV?
ACRV`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-10-20 04:35